- Home
- AZTA
AZTA
Azenta Inc.
as 11-15-2024 4:00pm EST
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has two reportable segments that are Life Sciences Products and Life Sciences Services. It generates a substantial part of its revenue from its Life Sciences Services segment.
| Founded: | 1978 | Country: | United States |
| Employees: | N/A | City: | BURLINGTON |
| Market Cap: | 2.2B | IPO Year: | 1995 |
| Target Price: | $63.60 | AVG Volume (30 days): | 533.4K |
| Analyst Decision: | Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.09 | EPS Growth: | N/A |
| 52 Week Low/High: | $40.24 - $69.16 | Next Earning Date: | 11-12-2024 |
| Revenue: | $656,323,000 | Revenue Growth: | -1.32% |
| Revenue Growth (this year): | 0.52% | Revenue Growth (next year): | 6.49% |
Stock Insider Trading Activity of Azenta Inc. (AZTA)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Cueto Herman | AZTA | EVP, Chief Financial Officer | Oct 17 '24 | Sell | $43.68 | 1,595 | $69,669.60 | 24,604 |
Latest Azenta Inc. News
AZTA Breaking Stock News: Dive into AZTA Ticker-Specific Updates for Smart Investing
Simply Wall St.
a day ago
Azenta, Inc. (NASDAQ:AZTA) Analysts Are Cutting Their Estimates: Here's What You Need To Know
PR Newswire
3 days ago
Azenta to Participate in Stephens Annual Investment Conference
Simply Wall St.
3 days ago
Calculating The Intrinsic Value Of Azenta, Inc. (NASDAQ:AZTA)
Simply Wall St.
3 days ago
Azenta Full Year 2024 Earnings: EPS Misses Expectations
GuruFocus.com
4 days ago
Azenta Inc (AZTA) Q4 2024 Earnings Call Highlights: Navigating Market Challenges with Strategic ...
Argus Research
5 days ago
AZTA: What does Argus have to say about AZTA?
PR Newswire
5 days ago
Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO
Argus Research
12 days ago
AZTA: Raising target price to $37.00
Compare AZTA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AZTA Azenta Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.